Table 4 Odds ratios for severe cases associated with TyG in whole population and in different subgroups
From: Association of the insulin resistance marker TyG index with the severity and mortality of COVID-19
Model1 | Model2 | Model3 | ||||
|---|---|---|---|---|---|---|
OR (95% CI) | P | OR (95% CI) | P | OR (95% CI) | P | |
Total | 2.8 (1.6–4.8) | 0.000 | 2.9 (1.2–6.3) | 0.007 | 2.3 (0.6–8.3) | 0.207 |
Subgroups | ||||||
Sex | ||||||
Male | 3.6 (1.6–8.2) | 0.002 | 5.7 (1.7–19.2) | 0.005 | 3.2 (0.4–22.7) | 0.246 |
Female | 2.8 (1.6–4.8) | 0.000 | 3.3 (1.5–7.0) | 0.003 | 2.6 (0.8–9.0) | 0.132 |
Age | ||||||
≥ 60 years | 2.6 (1.2–5.7) | 0.013 | 3.0 (1.2–7.3) | 0.014 | 5.4 (1.0–30.6) | 0.055 |
< 60 years | 1.8 (0.7–4.9) | 0.246 | 1.3 (0.2–8.5) | 0.773 | 0.6 (0.1–9.7) | 0.746 |
DM | ||||||
Yes | 6.5 (1.4–29.6) | 0.016 | 6.8 (1.3–34.8) | 0.021 | 6.0 (0.7–51.7) | 0.103 |
No | 1.9 (0.9–3.7) | 0.077 | 1.2 (0.6–2.7) | 0.630 | 1.2 (0.4–4.0) | 0.780 |
Hypertension | ||||||
Yes | 4.6 (1.6–13.3) | 0.006 | 4.3 (1.0–18.7) | 0.054 | 6.3 (0.6–64.2) | 0.121 |
No | 1.7 (0.8–3.5) | 0.138 | 1.8 (0.6–5.3) | 0.269 | 1.7 (0.3–8.6) | 0.520 |